President and CEO | Foxx Life Sciences

Independence Sale

00 Days
00 Hrs
00 Min
00 Sec
Order Now: (603) 890-3699
Cart 0

President and CEO

Thomas Foxx Taylor is President and CEO of Foxx Life Sciences (FLS). FLS designs and develops a wide variety of innovative laboratory, biotech, and pharmaceutical filtration, research, fluid management products. Taylor acquired the assets of Roush Life Sciences (RLS) in 2013. During his 5 years as President of RLS, over 600 products SKUs were developed with a wide variety innovative features and benefits.

​Before joining Roush in 2008, Taylor was President of Nypro Life Sciences, a division of Nypro Inc., a billion dollar global manufacturer of custom plastics offering integrated contract manufacturing. He held several other senior management positions with Nypro, including Vice President of Global Marketing and Business Development for Nypro’s 250 million dollar healthcare market segment, President of Nypro Medical Products Group, where he was responsible for initiatives on new proprietary medical products and technologies, and Vice President of Business Development. He also assisted in opening Nihon Nypro in Tokyo, he served as a board member on Nypro-Forbes India, a Nypro joint venture contract manufacturing company, Radius Product Development, a Nypro joint venture design firm, and NPA, a Nypro joint venture contract manufacturing company located in Mexico.

Prior to Nypro in 2003, Taylor was Vice President of the OEM Healthcare Business Unit at Millipore Corporation, where he led sales, marketing, research and development for all polymer membranes and medical devices for the global medical and diagnostic market.

An authority on practices and trends in the medical device market, Thomas serves on a number of association boards, industry advisory panels and editorial boards including MassMEDIC, Medical Products Outsourcing, and Emerging Life Sciences Alliance. In addition, he has written several articles on plastics, medical products, and outsourcing. In 2009, Taylor was voted Chairman of MassMEDIC, a New England Medical Device Industry Council with over 300 companies.

​Taylor is a graduate of Ferris State University with a degree in Plastics Engineering and holds an MBA from New Hampshire College. He and his family reside in New Hampshire.


Frequently Asked Questions

Assess your fluid handling volumes, sterility requirements, compatibility with solvents or reagents, and workflow endpoints. Foxx’s technical support team can assist in selecting assemblies and filtration components suited to your process.
Biotech, pharmaceutical manufacturing, vaccine production, research laboratories, clinical development, and diagnostic centres widely use Foxx single-use systems and consumables.
Yes. With global manufacturing facilities and strict quality control, Foxx products meet regulatory requirements in major markets including the US, EU, and Asia for scientific, clinical, and manufacturing applications.
Labs should follow regulatory guidelines for sterility assurance levels, validate fluid handling pathways, perform risk assessments per relevant standards (e.g., FDA, USP), and maintain traceability documentation for audit readiness. (Industry practice)
Yes. The company’s cleanroom manufacturing and quality certifications make its products suitable for Good Manufacturing Practice (GMP) environments where sterility and documentation standards are required.
Foxx Life Sciences offers Autofil® 2, EZlabpure™ and APEX™ bottle top filters, EZlabpure™ and EZFlow syringe filters, membrane disc filters, vent filters, and cell strainers engineered for high-purity filtration in analytical labs, bioprocessing, and cell culture workflows.
Foxx stands out for its ISO-certified quality, USP Class VI materials, extensive SKU portfolio with patented designs, rapid shipment, and global manufacturing footprint, providing superior compliance, performance, and cost value.
Foxx offers custom single-use solutions and assemblies designed to meet unique workflow requirements, enabling bespoke fluid paths, connectors, and tailored assemblies to optimize specific lab processes.
Standard Foxx products typically ship within 24–48 hours, while Made-to-Order (MTO) or custom SUT assemblies generally ship in 4–6 weeks, balancing speed with tailored specifications.
Single-use systems reduce contamination risk, eliminate cleaning and sterilization validation needs, cut turnaround times, lower labour and water use, and improve overall operational efficiency.
Foxx products are manufactured under ISO 13485 quality management systems in ISO Class 7 certified cleanrooms, use USP Class VI materials, and many are FDA registered. This ensures reliability, compliance, and suitability for regulated environments.
Single-Use Technology refers to disposable fluid handling and storage assemblies used in biopharmaceutical manufacturing and labs that eliminate traditional cleaning and sterilization processes, reducing contamination risk and operational complexity.
Foxx Life Sciences provides a broad range of life science and bioprocess consumables, including single-use systems (SUS), custom tubing & bottle assemblies, filtration products, lab safety equipment, glassware, plasticware, caps & gaskets, connectors, vent filters, and stainless-steel components for research, biotech, and pharmaceutical applications.
1 DAY ONLY!

CYBER MONDAY

Biggest Online Sale of the Year - Select Products [10%] [25%] [50% OFF!]

00 Days
00 Hours
00 Minutes
00 Seconds
Shop All Cyber Monday Deals

Hurry! Sale ends December 3rd at Midnight ET